Association between cataract surgery and type of implanted intraocular lens with sleep quality

Organizational Data

DRKS-ID:
DRKS00008728
Recruitment Status:
Recruiting complete, study complete
Date of registration in DRKS:
2015-06-05
Last update in DRKS:
2017-10-19
Registration type:
Prospective

Acronym/abbreviation of the study

No Entry

URL of the study

No Entry

Brief summary in lay language

In this trial, changes in sleep quality after cataract surgery will be noted. It is considered that the blue light affects the circadian rhythm of sleep and wakefulness, and that cataract acts as a filter of blue light and thus reduces the quality of sleep. Removing a cataract should increase the passage of light to the retina and thereby improve the quality of sleep. The quality of sleep will be examined using the "Pittsburgh sleep quality index" questionnaire before and after cataract surgery. It is a questionnaire that measures sleep quality in the last month using 18 questions. The questionnaire is filled out at least one month before and two months after surgery to avoid the stress that could affect the results.

Brief summary in scientific language

Sleep pattern is regulated via retinohypothalamic tract by stimulation of retinal ganglion cells, primarily with short wavelength light (blue light). With aging, the natural human lens opacifies and prevents passage of light to retina, and that may influence entrainment of circadian rhythms. Intraocular lenses with blue light filter were developed in order to prevent adverse effects of blue light to retina. In this study, quality of sleep before and after cataract surgery will be qualitatively and quantitatively measured using validated "Pittsburgh sleep quality index" questionnaire. The results will help determine that opaque human lens is partially responsible for poor sleep quality in elderly population, that the cataract surgery effectively improves sleep quality and determine whether there is difference in improving of sleep quality between patients with implantation of blue-light-filtering lens and ones with implantation of conventional intraocular lens (UV filter only).

Health condition or problem studied

ICD10:
h25 - Senile cataract
ICD10:
G47 - Sleep disorders
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
Phacoemulsification of cataract and implantation of blue-light-filtering intraocular lens
Arm 2:
Phacoemulsification of cataract and implantation of conventional (UV filter only) intraocular lens

Endpoints

Primary outcome:
Sleep quality, measured with PSQI one month before and 2 months after cataract surgery
Secondary outcome:
No Entry

Study Design

Purpose:
Other
Allocation:
Randomized controlled study
Control:
  • Active control (effective treatment of control group)
Phase:
N/A
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
Yes
Assignment:
Parallel
Sequence generation:
No Entry
Who is blinded:
  • Data analyst
  • Investigator/therapist
  • Patient/subject

Recruitment

Recruitment Status:
Recruiting complete, study complete
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Croatia
Number of study centers:
Monocenter study
Recruitment location(s):
  • University medical center Department of Ophthalmology Zagreb

Recruitment period and number of participants

Planned study start date:
2015-08-02
Actual study start date:
2015-08-10
Planned study completion date:
No Entry
Actual Study Completion Date:
2017-08-10
Target Sample Size:
220
Final Sample Size:
198

Inclusion Criteria

Sex:
All
Minimum Age:
60 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
having senile cataract; no usage of psychotropic drugs (due to impaired architectonics of sleep); no verified sleep disorders such as restless legs, sleep apnea, work in shifts; no previous eye surgeries; no diseases and disorders of the retina; having both eyes; no blurriness of other optical media; no eyelid ptosis; no end-stage glaucoma.

Exclusion Criteria

complications of cataract surgery; a change of type or dose of previously taken medications; starting of taking a new medication.

Addresses

Primary Sponsor

Address:
Department of Ophthalmology, University hospital centre Zagreb
Ivan Škegro
Kišpatićeva 12
10000 Zagreb
Croatia
Telephone:
+385 95 9015 642
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Department of Ophthalmology, University hospital centre Zagreb
Ivan Škegro
Kišpatićeva 12
10000 Zagreb
Croatia
Telephone:
+385 95 9015 642
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Contact for Public Queries

Address:
Department of Ophthalmology, University hospital centre Zagreb
Ivan Škegro
Kišpatićeva 12
10000 Zagreb
Croatia
Telephone:
+385 95 9015 642
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Principal Investigator

Address:
Department of Ophthalmology, University hospital centre Zagreb
Ivan Škegro
Kišpatićeva 12
10000 Zagreb
Croatia
Telephone:
+385 95 9015 642
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Sources of Monetary or Material Support

Institutional budget, no external funding (budget of sponsor/PI)

Address:
Department of Ophthalmology, University hospital centre Zagreb
Kišpatićeva 12
10000 Zagreb
Croatia
Telephone:
+385 95 9015 642
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Ethics Committee

Address Ethics Committee

Address:
University hospital Dubrava, Department of Radiology [Ethics Committee of University hospital Centre Zagreb; Ethics Committee of University of Zagreb School of Medicine ]
Prof. Boris Brkljačić
Avenija Gojka Šuška 6
10000 Zagreb
Croatia
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.mef.unizg.hr/druga.php?grupa=050600000000

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2014-02-02
Ethics committee number:
641-01/15-02/01
Vote of the Ethics Committee:
Approved
Date of the vote:
2014-07-08

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
U1111-1170-8477
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No Entry
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry